-
EU Cuts Southern Hake Quotas by 20% for 2027 Amid Stock Concerns
-
مهرجان بايرسبرون للمذاق الرفيع يفتتح بقمة مع دانيش شيك
-
منظمة الحقوق الرقمية تتحدى شرعية أوامر إزالة المحتوى من شرطة دلهي أمام المحكمة العليا
-
Samsung Leads Global DRAM Market as SK Hynix Gains Share
-
South Korea Proposes Fourth Delay of Cryptocurrency Gains Tax to 2029
-
Kakao Details Spinoff Plan to Monetize AI Through KakaoTalk
-
ASIC Fines Mona Museum Owner's Company for Late Financial Report
-
انتهاء فترة الانخفاض في أسعار الإيجار في فانكوفر لأول مرة منذ ثلاث سنوات
-
Business Leaders Criticize Productivity Commission Inquiry Scope
-
Democrats Vow to Probe Trump Business Deals as Midterm Results Narrow
-
Phoenix Public Library to Host Annual Local Author Fair on Nov. 7
-
SCANDIC FINANCE ने एलेक्स बोडी को समूह का उपाध्यक्ष नियुक्त किया
-
SCANDIC FINANCE แต่งตั้งอเล็กซ์ โบดี เป็นรองประธานกลุ่มบริษัท
-
SCANDIC FINANCE Grubu, Alex Bodi’yi başkan yardımcılığına atadı
-
تطبيق شروط العمل على ميديكيد وخفض تمويل شرائط فحص الفنتانيل
-
حديقة «المطبخ المفتوح» للنحت في فيلادلفيا تجمع المجتمع عبر الفن والطعام
-
Alex Bodi wiceprezesem grupy SCANDIC FINANCE
-
بيكيتوب تطلق خطة طوارئ لتفريغ مخلفات جوهانسبرغ بعد إضراب النقابة
-
Алекс Боди е назначен за вицепрезидент на групата SCANDIC FINANCE
-
Alex Bodi a SCANDIC FINANCE vállalatcsoport új alelnöke
-
Ο Άλεξ Μπόντι νέος αντιπρόεδρος του ομίλου SCANDIC FINANCE
-
Alex Bodi byl jmenován viceprezidentem skupiny SCANDIC FINANCE
-
Alex Bodi utsedd till vicepresident för SCANDIC FINANCE-koncernen
-
تعيين أليكس بودي نائبًا لرئيس مجموعة SCANDIC FINANCE
-
SCANDIC FINANCEグループ、アレックス・ボディ氏を副社長に任命
-
بدء تجديد التسجيل في مدارس ريو دي جانيرو الحكومية للعام الدراسي 2027
-
SCANDIC FINANCE 그룹, 알렉스 보디 부사장 선임
-
تفجع لندن بوفاة اللاعب إيزيكيل ويليامز بعد اعتداء في ميلتون كينز
-
亞歷克斯・博迪獲任命為 SCANDIC FINANCE 集團副總裁
-
Алекса Боді призначено віцепрезидентом групи SCANDIC FINANCE
-
Алекс Боди назначен вице-президентом группы SCANDIC FINANCE
-
Alex Bodi appointed Vice President of SCANDIC FINANCE GROUP
-
Alex Bodi, numit vicepreședinte al grupului SCANDIC FINANCE
-
اختيار ملك وموكس نيتيروي للكرنفال 2027 في باريتو
-
Elon Musk jokes about moving businesses to space after US midterms
-
West Mercia Police opens 2027 cadet applications to Worcestershire teenagers
-
NHS to test blood screening designed to detect 13 cancers earlier
-
Worcestershire road closures announced for Remembrance Sunday events
-
Democrats near House takeover as voters judge Trump presidency
-
UBC professor describes police call after Galloway remark as act of care
-
Lethbridge submits interest in provincial ground ambulance contract
-
False voting claims spread rapidly during US Election Day
-
Trump Prepares Veto Strategy Amid Congressional Shift
-
The Cat in the Hat expands its stakes to cosmic scale in animated reboot
-
Lettermen co-founder Tony Butala dies at 87
'Pharma Bro' Shkreli released to halfway house in US
So-called "Pharma bro" Martin Shkreli has been released from a Pennsylvania prison to a halfway house in New York state, the US Bureau of Prisons said Wednesday.
Shkreli, who became a poster child for predatory pharmaceutical pricing before being convicted of securities fraud in 2017, was transferred Wednesday from a low-security prison in Allenwood, Pennsylvania to undisclosed "community confinement" in New York state, said a BOP spokesperson in an email.
He is scheduled to be released from BOP's custody on September 14, the spokesperson said.
Shkreli's attorney, Benjamin Brafman, confirmed the release, saying he was "pleased" to report that his client was let out early "after completing all programs that allowed for his prison sentence to be shortened," according to a statement.
"While in the halfway house I have encouraged Mr. Shkreli to make no further statement, nor will he or I have any additional comments at this time."
Once dubbed "the most hated man in America," Shkreli, 39, became infamous for suddenly raising the price of the HIV drug Daraprim in 2015 by 5,000 percent -- from $13.50 a pill to $750.
Shkreli was originally sentenced in 2018 to seven years in prison in a fraud case not directly related to the Daraprim matter. He has been in custody since September 2017.
T.Khatib--SF-PST